Pain treatment in the field: Good for soldiers' comfort and better for rebuilding troop strengthDecember 18, 2007Noncombat-related acute and recurrent chronic pain are the leading causes of soldier attrition in modern war, with the return-to-duty rate as low as 2 percent when these soldiers are treated outside the theaters of operation. However, that rate jumps to 95 percent when troops and officers are treated and managed for pain in the field of instead of being sent elsewhere for therapy, according to a new study from a Johns Hopkins anesthesiologist. "The main factor seems to be rapid diagnosis and treatment of pain syndromes," says study co-author Colonel Steven Cohen, M.D., of the Department of Anesthesiology and Critical Care Medicine at the Johns Hopkins University School of Medicine. "Establishing pain treatment centers in combat areas gets care to soldiers fast and could dramatically increase the military's ability to maintain troop levels and succeed militarily in places like Iraq," says Cohen.
The report, appearing in the December issue of Anesthesiology, shows that 107 out of 113 soldiers suffering from noncombat-related pain were able to return to duty after being treated at the Ibna Sina Hospital in Baghdad between October 2005 and September 2006. In contrast, a previous study by Cohen and colleagues showed that of 162 soldiers with similar kinds of pain evacuated from Iraq for treatment at Walter Reed Army Medical Center in Washington, D.C., or the Landstuhl Regional Medical Center in Germany between April 2003 and July 2004, only three returned to active duty. Noncombat pain was defined in both studies as conditions resulting from such things as physical training, sports and accidents. Among those patients treated in the field, sciatica (leg pain and/or tingling, numbness or weakness that travels from the low back through the buttock and down the large sciatic nerve in the back of the leg) accounted for 55.7 percent of the cases; noncardiac chest pain, 11.5 percent; arm pain from a herniated disc in the neck, 7.1 percent; groin pain, 7.1 percent; leg pain, 7.1 percent; low back pain without leg symptoms, 6.2 percent; arm pain unrelated to a herniated disc, 1.8 percent; and neck pain/headache, 1.8 percent. All of the patients were seen within 72 hours of their initial complaints by anesthesiologists who are pain specialists. In the first study done in soldiers who were evacuated for treatment, the most common complaints were sciatica, low back pain, leg pain and arm pain. The majority of these cases did not receive definitive treatment until a few weeks after their initial complaints. Treatments for both sets of patients were similar and included epidural steroid injections, trigger point injections, lumbar interarticular facet blocks, groin blocks, corticosteroid injections, as well as nonsteroidal anti-inflammatory drugs, neuropathic pain drugs, muscle relaxants and opioids. "Early intervention is almost always associated with better outcomes," says Cohen. "The longer a pain complaint goes untreated, the worse the prognosis." Cohen says it is also more difficult to re-deploy soldiers once they are medically evacuated, for both logistical and psychological reasons. "Soldiers who stay with their units build on the strong ties with those units and wish to remain. Those bonds weaken when military personnel are stateside with their families, making theses soldiers even less amenable to returning to the field," he says. Johns Hopkins Medical Institutions | |||||||||||||||||||||
|
Related Pain Treatment News Articles Reviewers agree on osteoarthritis of the knee Concerns over the cardiovascular safety of non-steroidal anti-inflammatory drugs (NSAIDs) led to the publication of several sets of fresh guidelines on the treatment of knee osteoarthritis. Treatment blocks pain without disrupting other functions A combination of two drugs can selectively block pain-sensing neurons in rats without impairing movement or other sensations such as touch, according to a new study by National Institutes of Health (NIH)-supported investigators. New Treatment Guidelines For Low Back Pain A summary of evidence on the diagnosis and treatment of low-back pain has prompted the American Pain Society (ASP) and the American College of Physicians (ACP) to issue a new treatment guideline. Pain patients at risk for sleep apnea Opioid-based pain medications may cause sleep apnea, according to an article in the September issue of Pain Medicine, the journal of the American Academy of Pain Medicine. Supplemental therapy can ease pain for people suffering from common jaw disorder A new supplemental therapy that teaches pain coping and biofeedback skills can reduce pain, the potential for chronic pain and health-care costs for millions of Americans suffering from a common jaw disorder, UT Southwestern Medical Center researchers have found. New brain-chemistry differences found in depressed women A new brain study finds major differences between women with serious depression and healthy women in a brain-chemical system that's crucial to stress and emotions. Thinking the pain away? Study shows the brain's painkillers may cause 'placebo effect' Just thinking that a medicine will relieve pain is enough to prompt the brain to release its own natural painkillers, and soothe painful sensations, a new University of Michigan study finds. Antidepressants should be first-line approach for nerve tissue pain New reviews of previous studies confirm that older-style antidepressants, as well as anticonvulsant drugs, can help ease the disabling pain caused by nerve tissue damage. Surgery Patients Needed To Take Part In Cannabis Trial Patients scheduled for surgery are needed to take part in a Medical Research Council (MRC) study to find out if oral cannabis plant extract can provide pain relief after an operation. If found to be effective and without adverse side effects, it could provide another pain relief option to doctors and patients. Distance detection improves effect of spinal cord stimulation The effect of spinal cord stimulation, in chronic pain treatment, can be drastically improved using continuous distance detection. The strength of the stimulation pulses then depends on the distance measured between the electrodes and the spinal cord. In this way, negative side-effects belong to the past. These side-effects arise with a varying distance, causing diminished pain treatment in case of a distance that is too large, or unwanted sensations when the distance is too small. Emiel Dijkstra of the University of Twente developed a distance detection system. He finishes his PhD-research with the MESA+ research institute on February 27. Spinal cord stimulation is effective in treatment o More Pain Treatment News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||